- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nucleotide Variant
Total 4811 results
-
Fondazione Policlinico Universitario Agostino Gemelli...UnknownEpithelial Ovarian Cancer
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AGC Biologics S.p.A.CompletedOvarian Cancer Metastatic RecurrentItaly
-
Yonsei UniversityCompletedOvarian Cancer (Epithelial)Korea, Republic of
-
PharmaMar, SpainCompleted
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Chong Kun Dang PharmaceuticalCompletedEpithelial Ovarian CancerKorea, Republic of
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
New Mexico Cancer Care AllianceCelgene CorporationTerminatedOvarian Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of GlasgowCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest... and other collaboratorsTerminated
-
Liz-Anne LewsleyUnknownOvarian CancerUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian CancerUnited States
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)Completed
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
CanariaBio Inc.Korean Cancer Study GroupRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO StageKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Mỹ Đức HospitalRecruitingProgestins Primed Ovarian StimulationVietnam
-
Instituto BernabeuRecruitingIVF | LOW OVARIAN RESPONSESpain
-
Royan InstituteCompletedPoor Ovarian Response | AccupunctureIran, Islamic Republic of
-
Uludag UniversityCompleted
-
Alaa Fouli Gaber EbrahimUnknownOvarian Stimulation in ICSIEgypt
-
Guangzhou First People's HospitalUnknownLow Ovarian Reserve | GH
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedInfertility | Primary Ovarian InsufficiencyFrance
-
Benha UniversityCompletedOvarian HyperstimulationEgypt
-
EugoniaCompletedInfertility | Premature Ovarian FailureGreece
-
EugoniaCompletedInfertility | Premature Ovarian FailureGreece
-
Sorlandet Hospital HFUniversity of SurreyCompleted
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Centre Francois BaclesseGroupement Interrégional de Recherche Clinique et d'InnovationCompletedOvarian Cancer With Peritoneal CarcinosisFrance
-
Instituto de Investigacion Sanitaria La FeUnknownPremature Ovarian Failure (POF)Spain
-
Taipei Veterans General Hospital, TaiwanNational YangMing UniversityCompletedDehydroepiandrosterone | DHEAS | Gene Expression of Cumulus Cells. | Ovarian Hyper-stimulation Protocol. | Artificial Reproduction Technology.Taiwan
-
BioromaUnknownOvarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome | Invitro FertilizationItaly
-
University Hospital, ToursUnknown
-
Cybrexa TherapeuticsNot yet recruitingPlatinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
West China Second University HospitalRecruitingNeoadjuvant Chemotherapy | Epithelial Carcinoma, OvarianChina
-
Cukurova UniversityRecruitingEpithelial Ovarian Cancer | Rectosigmoid Cancer MetastaticTurkey
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Icahn School of Medicine at Mount SinaiWithdrawn